The Scientist

» pharma

Most Recent

Three investigations reveal the influence of industry money in patient advocacy groups, treatment guidelines, and Twitter feeds. 

0 Comments

image: Novartis Buys US Drugmaker for Up To $665 Million

Novartis Buys US Drugmaker for Up To $665 Million

By | November 23, 2016

The Swiss pharma giant is acquiring Oklahoma-based Selexys Pharmaceuticals, a maker of drugs for inflammatory and thrombotic diseases.

0 Comments

image: The Growth of Iowa Biotech

The Growth of Iowa Biotech

By | August 1, 2016

The state’s industry draws inspiration from medicine as well as agriculture.

1 Comment

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Shire Buys Rare Disease Drug Developer

Shire Buys Rare Disease Drug Developer

By | November 2, 2015

The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.

0 Comments

image: Daraprim Alternative

Daraprim Alternative

By | October 22, 2015

A specialty pharmaceuticals company announces plans to produce a toxoplasmosis drug containing the same active ingredient as the pill at the center of an ongoing drug-pricing controversy.

1 Comment

image: Biotech Stocks Take a Hit

Biotech Stocks Take a Hit

By | September 30, 2015

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

1 Comment

image: TS Picks: September 8, 2015

TS Picks: September 8, 2015

By | September 8, 2015

Pharma edition

0 Comments

image: Hearing Help

Hearing Help

By | September 1, 2015

For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.  

2 Comments

image: Valeant Scoops Sprout for $1 Billion

Valeant Scoops Sprout for $1 Billion

By | August 24, 2015

The Canadian pharmaceutical firm is buying the American drugmaker behind the newly approved “female Viagra.”

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS